Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Twist Bioscience Sees FY2026 Sales $425.000M-$435.000M vs $374.691M Est

Author: Benzinga Newsdesk | November 14, 2025 07:24am
Twist Bioscience (NASDAQ:TWST) sees FY2026 sales of $425.000 million-$435.000 million vs $374.691 million analyst estimate.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist